Quest Resource Holding Corp
For the period ended Dec 31, 2023. Filed Mar 12, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 12, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to the Consolidated Financial Statements
- The Company and Description of Business
The accompanying consolidated financial statements include the accounts of Quest Resource Holding Corporation (“QRHC”) and its subsidiaries, Quest Resource Management Group, LLC (“Quest”), Landfill Diversion Innovations, LLC (“LDI”), Youchange, Inc. (“Youchange”), Quest Vertigent Corporation (“QVC”), Quest Vertigent One, LLC (“QV One”), and Quest Sustainability Services, Inc. (“QSS”) (collectively, “we,” “us,” or “our company”). The subsidiaries RWS Facility Services, LLC (“RWS”), Sustainable Solutions Group, LLC (“SSG”), and Sequoia Waste Management Solutions, LLC (“Sequoia”) were merged into Quest in 2023 and were subsequently dissolved as separate legal entities.
Operations
We are a national provider of waste and recycling services to customers from across multiple industry sectors that are typically larger, multi-location businesses. We create customer-specific programs and perform the related services for the collection, processing, recycling, disposal, and tracking of waste streams and recyclables. In addition, we offer products such as antifreeze and windshield washer fluid and other minor ancillary services. We also provide information and data that tracks and reports the detailed transactional and environmental results of our services and provides actionable data to improve business operations. The data we generate also enables our customers to address their environmental and sustainability goals and responsibilities. Our principal office is located in The Colony, Texas within the Dallas metroplex.
On February 10, 2022, we acquired an independent environmental services company that primarily services customers in the northeast region of the United States. See Note 3 for more information regarding the acquisition.
- Summary of Significant Accounting Policies
Principles of Presentation and Consolidation
The consolidated financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The accompanying consolidated financial statements include the operating activity of QRHC and its subsidiaries for the years ended December 31, 2023 and 2022.
As Quest, LDI, Youchange, QVC, QV One, and QSS each operate as environmental-based service companies, we did not deem segment reporting necessary.
Accounting Estimates
The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could materially differ from those estimates.
We use estimates when accounting for the carrying amounts of accounts receivable, goodwill and other intangible assets, deferred taxes, and the fair value of assets and liabilities acquired in business acquisitions and stock-based compensation expense, all of which are discussed in their respective notes to the consolidated financial statements.
Revenue Recognition
We recognize revenue as services are performed or products are delivered. For example, we recognize revenue as waste and recyclable material are collected or when products are delivered. We recognize revenue net of any contracted pricing discounts or rebate arrangements.
We generally recognize revenue for the gross amount of consideration received as we are generally the primary obligor (or principal) in our contracts with customers as we hold complete responsibility to the customer for contract fulfillment. In situations in which we are not primarily obligated, we do not have credit risk, or we determine amounts earned using fixed percentage payment schedules, we record the revenue net of certain cost amounts. We record amounts collected from customers for sales tax on a net basis.
Cash and Cash Equivalents
We consider all highly liquid instruments with a maturity of three months or less when purchased to be cash equivalents.
Accounts Receivable
Our receivables, which are recorded when billed or when services are performed, are claims against third parties that will generally be settled in cash. The carrying value of our receivables, net of the allowance for doubtful accounts, represents the estimated net realizable value. We estimate our allowance for doubtful accounts based on consideration of a number of factors, including the length of time trade accounts are past due, our previous loss history, the creditworthiness of individual customers, economic conditions affecting specific customer industries, and economic conditions in general. We write off past-due receivable balances after all reasonable collection efforts have been exhausted. We credit payments subsequently received on such receivables to bad debt expense in the period we receive the payment.
As of December 31, 2023 and 2022, we had established an allowance of $1,581,595 and $2,176,010, respectively, for potentially uncollectible accounts receivable. We record delinquent finance charges on outstanding accounts receivable only if they are collected.
The changes in our allowance for doubtful accounts for the years ended December 31, 2023 and 2022, were as follows:
| Years ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Beginning balance | $2,176,010 | $840,522 |
| Bad debt expense | 1,746,877 | 1,737,169 |
| Uncollectible accounts written off, net | (2,341,292) | (401,681) |
| Ending balance | $1,581,595 | $2,176,010 |
Fair Value Measurements
Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements, defines fair value as the price that would be received in the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Topic 820 also specifies a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value as follows:
Level 1: Quoted prices in active markets for identical assets or liabilities;
Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
Level 3: Valuation is generated from model-based techniques that use significant assumptions not observable in the market. These unobservable assumptions reflect our own estimate of assumptions that market participants would use in pricing the asset or liability.
Property and Equipment
We record property and equipment at cost. We provide for depreciation on the straight-line method, over the estimated useful lives of the assets. We amortize leasehold improvements over the shorter of the estimated useful life or the remaining term of the related leases. We charge expenditures for repairs and maintenance to operations as incurred; we capitalize renewals and betterments when they extend the useful life of the asset. We record gains and losses on the disposition of property and equipment in the period incurred. We report assets held for sale, if any, at the lower of the carrying amount or fair value less costs to sell.
The useful lives of property and equipment for purposes of computing depreciation are as follows:
| Computer equipment | 3 to 5 years |
|---|---|
| Office furniture and fixtures | 5 to 7 years |
| Machinery and equipment | 5 to 7 years |
| Leasehold improvements | 5 to 7 years |
Impairment of Long-Lived Assets
We analyze long-lived assets, including property and equipment and definite-lived intangible assets, which are held and used in our operations, for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable. We review the amortization method and estimated period of useful life at least at each balance sheet date. We record the effects of any revision to operations when the change arises. We recognize impairment when the estimated undiscounted cash flow generated by those assets is less than the carrying amounts of such assets. The amount of impairment is the excess of the carrying amount over the fair value of such assets. We didnot recognize any impairment charges for long-lived assets during the years ended December 31, 2023 and 2022.
Goodwill
We record as goodwill the excess of the consideration transferred over the fair value of the net identifiable assets acquired. We do not amortize goodwill; however, annually, or whenever there is an indication that goodwill may be impaired, we evaluate qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. Our test of goodwill impairment includes assessing qualitative factors and the use of judgment in evaluating economic conditions, industry and market conditions, cost factors, and entity-specific events, such as market capitalization as compared to our book value. We performed our most recent goodwill impairment analysis in the third quarter of 2023 withno impairment recorded.
Net Income (Loss) per Share
We compute basic net income (loss) per share using the weighted average number of shares of common stock outstanding plus the number of common stock equivalents for Deferred Stock Units (“DSUs”), during the period. We compute diluted net income (loss) per share using the weighted average number of shares of common stock outstanding during the period, adjusted for the dilutive effect of common stock equivalents. Dilutive potential common shares consist of the incremental common shares issuable upon the exercise of outstanding stock options and warrants. Dilutive potential securities are excluded from the computation of earnings per share if their effect is antidilutive. The dilutive effect of outstanding stock options and warrants is reflected in diluted earnings per share by application of the treasury stock method.
Concentrations
Financial instruments that potentially subject us to credit risk consist principally of cash, cash equivalents, and trade accounts receivable. We deposit our cash with commercial banks. Cash deposits at commercial banks are at risk to the extent that the balances exceed the Federal Deposit Insurance Corporation insured level per institution. The bank cash balances on deposit may periodically exceed federally insured limits, however, we have never experienced any losses related to these balances.
We sell our services and products primarily to customers without requiring collateral; however, we routinely assess the financial condition of our customers and maintain allowances for anticipated losses. From year to year, the customers that exceed 10% of our annual revenue, if any, may change. The following table discloses the number of customers that accounted for more than 10% of our annual revenue and their related receivable balances for the years ended December 31, 2023 and 2022:
| Customers Exceeding 10%of Revenue | |||
|---|---|---|---|
| Year | Number ofCustomers | RevenueCombined Percent | Accounts ReceivableCombined Percent |
| 2023 | 2 | 29% | 18% |
| 2022 | 2 | 24% | 18% |
We believe we have no significant credit risk in excess of recorded reserves.
Leases
We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets and current and long-term operating lease liabilities on our consolidated balance sheets. We currently do not have any material finance lease arrangements.
Operating lease ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate in effect at the commencement date of the lease in determining the present value of future payments.
When we have the option to extend the lease term, terminate the lease before the contractual expiration date, or purchase the leased asset, and if it is reasonably certain that we will exercise the option, we consider these options in determining the classification and measurement of the lease. Leases with an initial term of 12 months or less are not recorded on the balance sheet.
We recognize deferred tax assets and liabilities for the future tax consequences of temporary differences between the book and tax basis of assets and liabilities that will result in taxable or deductible amounts in the future, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. We establish valuation allowances to reduce a deferred tax asset to the amount expected to be realized. We assess our ability to realize deferred tax assets based on current earnings performance and on projections of future taxable income in the relevant tax jurisdictions. These projections do not include taxable income from the reversal of deferred tax liabilities and do not reflect a general growth assumption but do consider known or pending events, such as the passage of legislation. We review our estimates of future taxable income annually.
If we are required to pay interest on the underpayment of income taxes, we recognize interest expense in the first period the interest becomes due according to the provisions of the relevant tax law.
If we are subject to payment of penalties, we recognize an expense for the amount of the statutory penalty in the period when the position is taken on the income tax return. If we did not recognize the penalty in the period when the position was initially taken, we recognize the expense in the period when we change our judgment about meeting minimum statutory thresholds related to the initial position taken.
Advertising
We charge our advertising costs to expense when incurred. During the years ended December 31, 2023 and 2022, advertising expense totaled $40,160 and $39,029, respectively.
Stock-Based Compensation
We measure all share-based payments, including grants of options to purchase common stock and the issuance of DSUs and RSUs to employees, third parties and board members, using a fair value-based method, in accordance with ASC Topic 718, Stock Compensation. All share-based awards have been classified as equity instruments and we recognize the vesting of the awards ratably over their respective terms. See Note 13 for a description of our share-based compensation plan and information related to awards granted under the plan.
We estimate the fair value of stock options using the Black-Scholes-Merton valuation model. Significant assumptions used in the calculation are as follows:
We have historically determined the expected term under the simplified method using an average of the contractual term and vesting period of the award. Beginning in 2023 we determine the expected life based on a weighted average of historical grants taking into account the vesting period of awards, time until exercise and expiration dates;
We measure the expected volatility using the historical changes in the market price of our common stock;
We use the implied yield on zero-coupon U.S. Treasury bonds with a remaining maturity equal to the expected term of the awards to approximate the risk-free interest rate; and
We recognize the effects of forfeitures in compensation cost when they occur.
Deferred Stock Units
Non-employee directors can elect to receive all or a portion of their annual retainers in the form of DSUs. The DSUs are recognized at their fair value on the date of grant. Director fees deferred into stock units are calculated and expensed each month by taking fees earned during the month and dividing by the closing price of our common stock on the last trading day of the month, rounded down to the nearest whole share. Each DSU represents the right to receiveone share of our common stock following the completion of a director’s service. In addition, certain executive compensation expense is also granted in the form of DSUs.
Restricted Stock Units
Beginning in 2023, non-employee directors received their annual board compensation in the form of restricted stock units (“RSU”s). The RSUs are recognized at their fair value on the date of grant. Each RSU represents the right to receive one share of our common stock once fully vested.
Business Combinations
Our acquisitions are accounted for in accordance with ASC Topic 805, Business Combinations. In purchase accounting, identifiable assets acquired and liabilities assumed are recognized at their estimated fair values at the acquisition date, and any remaining purchase price is recorded as goodwill. In determining the fair values of assets acquired and liabilities assumed, we make significant estimates and assumptions, particularly with respect to long-lived tangible and intangible assets. Critical estimates used in valuing tangible and intangible assets include, but are not limited to, future expected cash flows, discount rates, market prices and asset lives. See Note 3 for more information related to our most recent acquisition.
Our consolidated financial statements include the results of operations from the date of such acquisition.
We expense all acquisition-related costs as incurred in selling, general and administrative expenses in the consolidated statements of operations.
Recent Accounting Pronouncements
Adopted
In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326), which provides guidance on measuring credit losses on financial instruments. The amended guidance replaces current incurred loss impairment methodology of recognizing credit losses when a loss is probable with a new forward-looking approach to estimate expected credit losses. We adopted the new standard on January 1, 2023. The adoption of the new standard did not have a material impact on our condensed consolidated financial statements as pre-existing processes for estimating expected credit losses for trade receivables generally aligned with the expected credit loss model.
Pending Adoption
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires incremental disclosures related to reportable segments, including significant segment expense categories and amounts for each reportable segment. Entities with a single reportable segment are required to provide the new disclosures required under ASC 280. This authoritative guidance is required to be applied retrospectively and will be effective for our annual disclosures beginning in 2024 and interim periods starting 2025. This guidance is only related to disclosures and is not expected to have a significant impact on our consolidated financial statements.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires entities to provide additional disclosure related to the transparency and decision usefulness of income tax disclosures, including additional disclosure around the rate reconciliation and income taxes paid. The authoritative guidance should be applied prospectively and will be effective for us starting in 2025. Retrospective application is permitted. This guidance is only related to disclosures and is not expected to have a significant impact on our consolidated financial statements.
There have been no other recent accounting pronouncements or changes in accounting pronouncements that have been issued but not yet adopted that are of significance, or potential significance, to us.
- Acquisition
On February 10, 2022, we acquired an independent environmental services company that primarily services customers in the northeast region of the United States for approximately $3.35 million. This acquisition was paid in cash and was financed with a draw down on the term loan pursuant to the Credit Agreement (as defined in Note 7). The purchase price was allocated to the acquired assets, primarily customer relationship intangibles and goodwill.
- Property and Equipment, net, and Other Assets
At December 31, 2023 and 2022, Property and equipment, net, and other assets consisted of the following:
| As of December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Machinery and equipment | $3,321,220 | $3,159,483 |
| Office furniture and fixtures | 573,686 | 568,040 |
| Leasehold improvements | 715,312 | 719,781 |
| Computer equipment | 451,329 | 676,197 |
| Property and equipment, gross | 5,061,547 | 5,123,501 |
| Accumulated depreciation | (2,932,371) | (2,499,797) |
| Property and equipment, net | 2,129,176 | 2,623,704 |
| Right-of-use operating lease assets | 1,862,455 | 2,385,870 |
| Security deposits and other assets | 634,459 | 901,653 |
| Property and equipment, net, and other assets | $4,626,090 | $5,911,227 |
We compute depreciation using the straight-line method over the estimated useful lives of the property and equipment. Depreciation expense for the year ended December 31, 2023 was $805,821, including $377,872 of depreciation expense reflected within “Cost of revenue” in our consolidated statement of operations as it related to assets used directly in servicing customer contracts. Depreciation expense for the year ended December 31, 2022 was $744,858, including $316,405 of depreciation expense reflected within “Cost of revenue” in our consolidated statement of operations as it related to assets used directly in servicing customer contracts.
We recorded right-of-use operating lease assets related to our office leases in accordance with ASC 842. Refer to Note 8, Leases for additional information.
On February 20, 2018 (the “Closing Date”), we entered into an Asset Purchase Agreement with Earth Media Partners, LLC to sell certain assets of our wholly owned subsidiary, Earth911, Inc., in exchange for a 19% interest in Earth Media Partners, LLC, which was recorded as an investment in the amount of $246,585 as of the Closing Date, and a potential future earn-out amount of approximately $350,000. The net assets sold related to the Earth911.com website business and consisted primarily of the website and its content and customers, deferred revenues, and accounts receivable as of the Closing Date. Earth911, Inc. was subsequently renamed Quest Sustainability Services, Inc. The carrying amount of our investment in Earth Media Partners, LLC is included in “Security deposits and other assets” and we have an accrued receivable in the amount of $320,167 and $327,667 related to the earn-out as of December 31, 2023 and 2022, respectively.
- Goodwill and Other Intangible Assets
The components of goodwill and other intangible assets are as follows:
| December 31, 2023 | EstimatedUseful Life | Gross CarryingAmount | AccumulatedAmortization | Net |
|---|---|---|---|---|
| Finite lived intangible assets: | ||||
| Customer relationships | 5 years | $39,250,000 | $17,636,463 | $21,613,537 |
| Software | 7 years | 4,230,291 | 1,819,287 | 2,411,004 |
| Trademarks | 7 years | 2,026,163 | 657,331 | 1,368,832 |
| Non-compete agreements | 3 years | 2,250,000 | 1,591,945 | 658,055 |
| Total finite lived intangible assets | $47,756,454 | $21,705,026 | $26,051,428 | |
| December 31, 2022 | EstimatedUseful Life | Gross CarryingAmount | AccumulatedAmortization | Net |
|---|---|---|---|---|
| Finite lived intangible assets: | ||||
| Customer relationships | 5 years | $39,250,000 | $9,808,855 | $29,441,145 |
| Software | 7 years | 2,609,374 | 1,541,500 | 1,067,874 |
| Trademarks | 7 years | 2,009,403 | 370,137 | 1,639,266 |
| Non-compete agreements | 3 years | 2,250,000 | 841,945 | 1,408,055 |
| Total finite lived intangible assets | $46,118,777 | $12,562,437 | $33,556,340 | |
| CarryingAmount | |
|---|---|
| Changes in goodwill: | |
| Balance at December 31, 2021 | $80,621,503 |
| Addition related to acquisitions | 541,766 |
| RWS purchase price allocation adjustment | 3,594,937 |
| Purchase price adjustment | (500,000) |
| Balance at December 31, 2022 | $84,258,206 |
| RWS pre-acquisition adjustments | 1,570,032 |
| Balance at December 31, 2023 | $85,828,238 |
We compute amortization using the straight-line method over the estimated useful lives of the finite lived intangible assets. The amortization expense related to finite lived intangible assets was approximately$9.1 million and$9.2 million for the years ended December 31, 2023 and 2022, respectively.
We estimate future amortization expense as of December 31, 2023 to be approximately as follows:
| Year Ending December 31, | Amount |
|---|---|
| 2024 | $9,150,459 |
| 2025 | 8,302,642 |
| 2026 | 6,704,479 |
| 2027 | 665,909 |
| 2028 | 559,417 |
| Thereafter | 668,522 |
| Total | $26,051,428 |
We haveno indefinite-lived intangible assets other than goodwill.$70.8 million of the goodwill is not deductible for tax purposes, while$15.0 million of goodwill added in the prior years is deductible over its tax-basis life. We performed our goodwill impairment analysis in the third quarter of 2023 and 2022 withno impairment recorded in either period.
In 2023, we recorded a correction to the goodwill from the RWS acquisition completed in 2021. This adjustment resulted in a net increase of $1.6 million and $2.7 million to goodwill and accounts payable, respectively. We assessed the materiality of this correction on our consolidated financial statements for the year ended December 31, 2021 and concluded that the effect of this correction was not material, quantitatively or qualitatively, to the consolidated financial statements taken as a whole, or for any of the subsequent reporting periods. Accordingly, we recorded a charge to cost of revenue of $1.2 million in the fourth quarter of 2023, which was equally attributable to 2021 and 2022.
In 2022, our adjustments to goodwill included a $3.6 million adjustment related to the RWS acquisition, $0.5 million related to our acquisition of an independent environmental services company, and $(0.5) million related to a prior year purchase price adjustment. In addition, in 2022 we recorded $2.8 million of intangible assets as part of our acquisition of an independent environmental services company. See Note 3 for more information on the 2022 acquisition.
- Current Liabilities
The components of Accounts payable and accrued liabilities are as follows:
| As of December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Accounts payable | $38,600,461 | $28,744,858 |
| Accrued taxes | 484,854 | 331,936 |
| Employee compensation | 1,478,826 | 1,812,028 |
| Operating lease liability - current portion | 493,928 | 489,938 |
| Miscellaneous | 238,097 | 828,701 |
| $41,296,166 | $32,207,461 | |
Refer to Note 8 for additional disclosure related to the operating lease liability.
The components of Other current liabilities are as follows:
| As of December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Deferred revenue | $1,509,690 | $2,731,350 |
| Deferred consideration - earn-out | 960,000 | 1,957,255 |
| $2,469,690 | $4,688,605 | |
We made a $1.2 million earnout payment in 2023 related to an acquisition.
- Notes Payable
Our debt obligations are as follows:
| Years ended December 31, | |||
|---|---|---|---|
| Interest Rate (1) | 2023 | 2022 | |
| Monroe Term Loan (2) | 11.96% | $53,500,656 | $61,073,151 |
| Green Remedies Promissory Note (3) | 3.00% | 1,101,120 | 1,637,970 |
| PNC ABL Facility (4) | 7.50% | 13,245,489 | 12,238,034 |
| Total notes payable | 67,847,265 | 74,949,155 | |
| Less: Current portion of long-term debt | (1,158,800) | (1,158,800) | |
| Less: Unamortized debt issuance costs | (1,345,339) | (2,122,715) | |
| Less: Unamortized OID | (185,793) | (288,643) | |
| Less: Unamortized OID warrant | (519,153) | (806,106) | |
| Notes payable, net | $64,638,180 | $70,572,891 | |
| (2) Bears interest based on SOFR plus Applicable Margin ranging from 5.5% to 7.5% | |||
| (3) Stated interest rate of 3.0% | |||
| (4) Bears interest based on Adjusted Term SOFR plus a margin ranging from 1.75% to 2.25% | |||
The future minimum principal payments as of December 31, 2023 are as follows:
| Year Ending December 31, | Amount |
|---|---|
| 2024 | $1,158,850 |
| 2025 | 66,688,415 |
| Total | $67,847,265 |
We capitalize financing costs we incur related to implementing our debt arrangements. We record these debt issuance costs associated with our revolving credit facility and our term loan as a reduction of long-term debt, net and amortize them over the contractual life of the related debt arrangements. The table below summarizes changes in debt issuance costs.
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Debt issuance costs | ||
| Beginning balance | $2,122,715 | $2,637,483 |
| Financing costs deferred | — | 214,550 |
| Less: Amortization expense | (777,376) | (729,318) |
| Debt issuance costs, net of accumulated amortization | $1,345,339 | $2,122,715 |
Revolving Credit Facility
On August 5, 2020, QRHC and certain of its subsidiaries entered into a Loan, Security and Guaranty Agreement (the “PNC Loan Agreement”), which was subsequently amended on October 19, 2020, December 7, 2021, August 9, 2022 and December 2, 2022, with BBVA USA (which was subsequently succeeded in interest by PNC Bank, National Association (“PNC”)), as a lender, and as administrative agent, collateral agent, and issuing bank, which provides for a credit facility (the “ABL Facility”) comprising an asset-based revolving credit facility in the maximum principal amount of $25.0 million with a sublimit for issuance of letters of credit of up to 10% of the maximum principal amount of the revolving credit facility. The revolving credit facility bears interest, at the borrowers’ option, at either the Base Rate, plus a margin ranging from 0.75% to 1.25% (no borrowings as of December 31, 2023), or the Adjusted Term SOFR Rate for the interest period in effect plus a margin ranging from 1.75% to 2.25% (7.50% as of December 31, 2023). The maturity date of the revolving credit facility is April 19, 2025. The revolving credit facility contains an accordion feature, subject to PNC’s approval, permitting the revolving credit facility to be increased by up to $10 million.
Certain of QRHC’s subsidiaries are the borrowers under the PNC Loan Agreement. QRHC and one of its subsidiaries are guarantors under the PNC Loan Agreement. As security for the obligations of the borrowers under the PNC Loan Agreement, (i) the borrowers under the PNC Loan Agreement have granted a first priority lien on substantially all of their tangible and intangible personal property, including a pledge of the capital stock and membership interests, as applicable, of certain of QRHC’s direct and indirect subsidiaries, and (ii) the guarantors under the PNC Loan Agreement have granted a first priority lien on the capital stock and membership interests, as applicable, of certain of QRHC’s direct and indirect subsidiaries.
The PNC Loan Agreement contains certain financial covenants, including a minimum fixed charge coverage ratio. In addition, the PNC Loan Agreement contains negative covenants limiting, among other things, additional indebtedness, transactions with affiliates, additional liens, sales of assets, dividends, investments and advances, prepayments of debt, mergers and acquisitions, and other matter customarily restricted in such agreements. The PNC Loan Agreement also contains customary events of default, including payment defaults, breaches of representations and warranties, covenant defaults, events of bankruptcy and insolvency, change of control, and failure of any guaranty or security document supporting the PNC Loan Agreement to be in full force and effect. Upon the occurrence of an event of default, the outstanding obligations under the PNC Loan Agreement may be accelerated and become immediately due and payable.
As of December 31, 2023, the ABL Facility borrowing base availability was $25,000,000, of which$13,245,489 principal was outstanding.
Monroe Term Loan
On October 19, 2020, QRHC and certain of its subsidiaries entered into a Credit Agreement (the “Credit Agreement”), dated as of October 19, 2020, which was subsequently amended on September 3, 2021, December 1, 2021, December 7, 2021, August 9, 2022, and December 2, 2022, with Monroe Capital Management Advisors, LLC (“Monroe Capital”), as administrative agent for the lenders thereto. Among other things, the Credit Agreement provides for the following:
A senior secured term loan facility in the principal amount of $53.5 million as of December 31, 2023. The senior secured term loan accrues interest at the SOFR Rate for SOFR Loans plus the Applicable Margin; provided, that if the provision of SOFR Loans becomes unlawful or unavailable, then interest will be payable at a rate per annum equal to the Base Rate from time to time in effect plus the Applicable Margin for Base Rate Loans. The maturity date of the term loan facility is October 19, 2025 (the “Maturity Date”). The senior secured term loan will amortize in aggregate annual amounts equal to 1.00% of the original principal amount of the senior secured term loan facility with the balance payable on the Maturity Date. Proceeds of the senior secured term loan are permitted to be used for Permitted Acquisitions (as defined in the Credit Agreement)
An accordion term loan facility in the maximum principal amount of $5.3 million. Loans under the accordion loan facility may be requested at any time until the Maturity Date. Each accordion term loan shall be on the same terms as those applicable to the senior secured term loan. Proceeds of accordion term loans are permitted to be used for Permitted Acquisitions.
Certain of QRHC’s subsidiaries are the borrowers under the Credit Agreement. QRHC is the guarantor under the Credit Agreement. As security for the obligations of the borrowers under the Credit Agreement, (i) the borrowers under the Credit Agreement have granted a first priority lien on substantially all of their tangible and intangible personal property, including a pledge of the capital stock and membership interests, as applicable, of certain of QRHC’s direct and indirect subsidiaries, and (ii) the guarantors under the Credit Agreement have granted a first priority lien on the capital stock and membership interests, as applicable, of QRHC’s direct and indirect subsidiaries.
The Credit Agreement contains certain financial covenants, including a minimum fixed charge coverage ratio and a senior net leverage ratio. In addition, the Credit Agreement contains negative covenants limiting, among other things, additional indebtedness, transactions with affiliates, additional liens, sales of assets, dividends, investments and advances, prepayments of debt, mergers and acquisitions, and other matters customarily restricted in such agreements. The Credit Agreement also contains customary events of default, including payment defaults, breaches of representations and warranties, covenant defaults, events of bankruptcy and insolvency, change of control, and failure of any guaranty or security document supporting the Credit Agreement to be in full force and effect. Upon the occurrence of an event of default, the outstanding obligations under the Credit Agreement may be accelerated and become immediately due and payable.
At the same time as the borrowing of the initial $11.5 million under the Credit Agreement in October 2020, in a separate agreement, we issued Monroe Capital a warrant to purchase 500,000 shares of QRHC’s common stock exercisable immediately. For the delayed draw term loan facility, we issued a separate warrant to purchase 350,000 shares upon drawing on this facility on October 19, 2021. Both warrants have an exercise price of $1.50 per share and an expiration date of March 19, 2028. We estimated the grant-date fair value of the warrants issued using the Black Scholes option pricing model and recorded a debt discount of approximately $766,000 in 2020 for the 500,000-share warrant and $536,000 in 2021 for the 350,000-share warrant which are being amortized over the term of the Credit Agreement. We also executed a letter agreement that provides that the warrant holder will receive minimum net proceeds of $1 million less any net proceeds received from the sale of the warrant shares, which is conditional on the full exercise and sale of all the warrant shares at the same time and upon a date two years after the closing date of such agreement.
Green Remedies Promissory Note
On October 19, 2020, we issued an unsecured subordinated promissory note to the seller of Green Remedies in the aggregate principal amount of $2,684,250, payable commencing on January 1, 2021 in quarterly installments through October 1, 2025 and subject to an interest rate of 3.0% per annum.
Interest Expense
The amount of interest expense related to borrowings for the years ended December 31, 2023 and 2022 was $7,785,516 and $6,002,649, respectively. Debt issuance cost of $3,323,906 is being amortized to interest expense over the lives of the related debt arrangements. Interest expense related to amortization of debt issuance fees, debt discount costs and interest related to vendor supply chain financing programs was $1,943,582 and $1,278,092, respectively, for the years ended December 31, 2023 and 2022.
- Leases
Our leases are primarily related to office space and are classified as operating leases for which we recorded a right of use asset at the inception or amendment of each lease. Our primary leases include:
Primary headquarters in The Colony, Texas. On September 29, 2022, we executed an amendment to our corporate office lease, pursuant to which we reduced the amount of square space rented to approximately 16,200 square feet and extended the term from October 2022 to December 31, 2027. We recorded a right of use asset associated with this lease of approximately $1.6 million. This lease had a remaining termof 4.0 years at December 31, 2023. We used an effective interest rate of 4.56%, which was our incremental borrowing rate in effect at the date of the lease amendment as the lease does not provide a readily determinable implicit rate.
Chadds Ford, PA office. We recorded a right of use asset associated with this lease, which was modified in 2022, of approximately $716,000. The lease expires in October 2026. This lease had a remaining term of 2.8 years at December 31, 2023, and we used an effective interest rate of 7.5%, which was our incremental borrowing rate in effect at the acquisition date of RWS as the lease does not provide a readily determinable implicit rate. This lease may be terminated under certain conditions as defined in the lease agreement.
Greenville, SC office. We recorded a right of use asset associated with this lease of approximately $255,000. The lease expires in December 2024. This lease had a remaining term of 0.9 years at December 31, 2023, and we used an effective interest rate of 8.75%, which was our incremental borrowing rate in effect at the acquisition date of the lease as the lease does not provide a readily determinable implicit rate. This lease may be terminated under certain conditions as defined in the lease agreement.
Burlington, NC office. Our office lease in Burlington, NC was terminated effective December 31, 2023. The lessor was a related party that is owned by the seller of Green Remedies, which was acquired by us in 2020.
The future minimum lease payments required under our office leases as of December 31, 2023 are as follows:
| Year Ending December 31, | Amount |
|---|---|
| 2024 | $573,969 |
| 2025 | 495,161 |
| 2026 | 484,441 |
| 2027 | 387,909 |
| Total lease payments | 1,941,480 |
| Less: Interest | (172,861) |
| Present value of lease payments | $1,768,619 |
Balance Sheet Classification
The table below presents the lease related assets and liabilities recorded on the balance sheet. Right-of-use assets and related liabilities related to finance leases as of December 31, 2023 and 2022 are de minimis.
| As of December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Operating Leases | ||
| Right-of-use operating lease assets: | ||
| Property and equipment, net and other assets | $1,862,455 | $2,385,870 |
| Lease liabilities: | ||
| Accounts payable and accrued liabilities | $493,928 | $489,938 |
| Other long-term liabilities | 1,274,691 | 1,724,244 |
| Total operating lease liabilities | $1,768,619 | $2,214,182 |
Lease Costs
For the years ended December 31, 2023 and 2022, we recorded $753,818 and $946,840, respectively, of fixed cost operating lease expense.
Cash paid for operating leases approximated operating lease expense and non-cash right of use asset amortization for the years ended December 31, 2023 and 2022.
- Revenue
Operating Revenues
We provide businesses with services to reuse, recycle, and dispose of a wide variety of waste streams and recyclables generated by their operations. Service revenues are primarily generated from fees charged for our collection, transfer, disposal and recycling services and from sales of commodities by our recycling operations. In addition, we have product sales and other revenue primarily from sales of products such as antifreeze and windshield washer fluid, as well as minor ancillary services.
Revenue Recognition
We recognize revenue as services are performed or products are delivered. For example, we recognize revenue as waste and recyclable material are collected or when products are delivered. We recognize revenue net of any contracted pricing discounts or rebate arrangements.
We generally recognize revenue for the gross amount of consideration received as we are generally the primary obligor (or principal) in our contracts with customers as we hold complete responsibility to the customer for contract fulfillment. Depending on the key terms of the arrangement, which may include situations in which we are not primarily obligated, we do not have credit risk, or we determine amounts earned using fixed percentage or fixed fee schedules, we may record the revenue net of certain cost amounts. We had certain management fee contracts accounted for under the net basis method with net revenue of $445,107 and $484,229 for the years ended December 31, 2023 and 2022, respectively. We record amounts collected from customers for sales tax on a net basis.
Disaggregation of Revenue
The following table presents our revenue disaggregated by source. Two customers accounted for 29% of revenue for the year ended December 31, 2023, andtwo customers accounted for 24% of revenue for the year ended December 31, 2022. We operate primarily in the United States, with minor services in Canada.
| Year Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Revenue Type: | ||
| Services | $277,280,099 | $273,796,746 |
| Product sales and other | 11,097,553 | 10,241,077 |
| Total revenue | $288,377,652 | $284,037,823 |
Contract Balances
Our incremental direct costs of obtaining a customer contract are generally deferred and amortized to selling, general, and administrative expense or as a reduction to revenue (depending on the nature of the cost) over the estimated life of the customer contract. We classify our contract acquisition costs as current or noncurrent based on the timing of when we expect to recognize the amortization and are included in other assets.
As of December 31, 2023 and 2022 we had $0 and $566,667, respectively, of deferred contract costs. During the year ended December 31, 2023 and 2022, we amortized $333,333 and $408,333, respectively, of deferred contract costs to selling, general, and administrative expense.
We bill certain customers one month in advance, and, accordingly, we defer recognition of related revenues as a contract liability until the services are provided and control is transferred to the customer. As of December 31, 2023 and 2022, we had $1,509,690 and $2,731,350, respectively, of deferred revenue, which was classified in “Other current liabilities.”
- Income Taxes
We compute income taxes using the asset and liability method in accordance with FASB ASC Topic 740, Income Taxes. Under the asset and liability method, we determine deferred income tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities and measure those using currently enacted tax rates and laws. We provide a valuation allowance for the amount of deferred tax assets that, based on available evidence, are more likely than not to be realized. Realization of our net operating loss carryforward was not reasonably assured as of December 31, 2023 and 2022, and we have recorded a valuation allowance of $17,413,000 and $13,999,000, respectively against deferred tax assets in excess of deferred tax liabilities in the accompanying consolidated financial statements.
The components of net deferred taxes are as follows:
| As of December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Deferred tax assets (liabilities): | ||
| Net operating loss | $1,531,000 | $1,447,000 |
| Depreciation and amortization | 7,336,000 | 5,490,000 |
| Stock-based compensation | 4,780,000 | 4,638,000 |
| Interest expense | 2,952,000 | 1,276,000 |
| Capitalized software costs | (53,000) | (278,000) |
| Bonus accrual | 210,000 | 284,000 |
| Allowance for doubtful accounts | 412,000 | 567,000 |
| Other | 245,000 | 575,000 |
| Total deferred tax assets, net | 17,413,000 | 13,999,000 |
| Less: valuation allowance | (17,413,000) | (13,999,000) |
| Net deferred taxes | $— | $— |
Our statutory income tax rate is expected to be approximately 26%. We had state income tax expense of $386,932 and $172,604 for the years ended December 31, 2023 and 2022, respectively, which is attributable to state obligations for states withno net operating loss carryforwards, and the continued reserve against the benefit of the net operating losses at the federal level. The provision for income taxes consisted of the following:
| Years Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Current | $386,932 | $172,604 |
| Deferred | — | — |
| Total | $386,932 | $172,604 |
The reconciliation between the income tax expense calculated by applying statutory rates to net income (loss) and the income tax expense reported in the accompanying consolidated financial statements is as follows:
| Years Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| U.S. federal statutory rate applied to pretax loss | $(1,450,000) | $(1,234,000) |
| State taxes - current, net of federal benefit | 386,932 | 172,604 |
| State taxes - deferred | (428,000) | (411,000) |
| Permanent differences | (306,000) | (471,000) |
| Benefit of federal operating loss carryforwards | (332,000) | (845,000) |
| Change in state tax rates and other | (898,000) | 100,000 |
| Change in valuation allowance | 3,414,000 | 2,861,000 |
| $386,932 | $172,604 | |
As of December 31, 2023 and 2022, we had federal income tax net operating loss carryforwards of approximately $5,900,000 and $5,600,000, respectively, which expire at various dates ranging from 2034 through 2037. We are subject to limitations existing under Internal Revenue Code Section 382 (Change of Control) relating to the availability of the operating loss, therefore utilization of a portion of the Company's net operating loss may be limited in future years.
As of December 31, 2023 and 2022, we did not recognize any assets or liabilities relative to uncertain tax positions, nor do we anticipate any significant unrecognized tax benefits will be recorded during 2024. It is our policy to classify interest and penalties on income taxes as interest expense or penalties expense, should any be incurred.
Tax positions are positions taken in a previously filed tax return or positions expected to be taken in a future tax return that are reflected in measuring current or deferred income tax assets and liabilities reported in the financial statements. Tax positions include the following:
an allocation or shift of income between taxing jurisdictions;
the characterization of income or a decision to exclude reportable taxable income in a tax return; or
a decision to classify a transaction, entity, or other position in a tax return as tax exempt.
We are potentially subject to tax audits for federal and state tax returns for tax years ended 2019 to 2023. Tax audits by their very nature are often complex and can require several years to complete.
- Fair Value of Financial Instruments
Our financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, accrued liabilities, deferred revenue and notes payable. We do not believe that we are exposed to significant currency or credit risks arising from these financial instruments. Our variable rate indebtedness subjects us to interest rate risk as all of the borrowings under the senior secured credit facilities bear interest at variable rates. The fair values of our financial instruments approximate their carrying values, based on their short maturities or, for notes payable, based on borrowing rates currently available to us for loans with similar terms and maturities. Contingent liabilities are measured at fair value on a recurring basis. The fair value measurements are generally determined using unobservable inputs and are classified within Level 3 of the fair value hierarchy.
- Commitments and Contingencies
Indemnifications
During the normal course of business, we make certain indemnities and commitments under which we may be required to make payments in relation to certain transactions. These may include (i) intellectual property indemnities to customers in connection with the use, sales, and/or license of products and services; (ii) indemnities to customers in connection with losses incurred while performing services on their premises; (iii) indemnities to vendors and service providers pertaining to claims based on negligence or willful misconduct; and (iv) indemnities involving the representations and warranties in certain contracts. In addition, under our bylaws we are committed to our directors and officers for providing for payments upon the occurrence of certain prescribed events. The majority of these indemnities and commitments do not provide for any limitation on the maximum potential for future payments that we could be obligated to make. We have not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. As a result, we believe the estimated fair value of these agreements is minimal. Accordingly, we hadno liabilities recorded for these agreements as of December 31, 2023 and 2022.
Defined Contribution Plan
We maintain a defined contribution 401(k) plan covering substantially all full-time employees. Employees are permitted to make voluntary contributions, which we match at a certain percentage, to the plan. For the years ended December 31, 2023 and 2022, our plan contribution expense was $348,781 and $270,477, respectively.
- Stockholders’ Equity
Preferred Stock
Our authorized preferred stock consists of 10,000,000 shares of preferred stock with a par value of $0.001, of whichno shares have been issued or were outstanding as of December 31, 2023 and 2022. Preferred stock is to be designated in classes or series and the number of each class or series and the voting powers, designations, preferences, limitations, restrictions, relative rights, and distinguishing designation of each class or series of stock as the Board of Directors shall determine in its sole discretion.
Common Stock
Our authorized common stock consists of 200,000,000 shares of common stock with a par value of $0.001, of which 20,161,400 and 19,696,006 shares were issued and outstanding as of December 31, 2023 and 2022, respectively.
Employee Stock Purchase Plan
On September 17, 2014, our stockholders approved our 2014 Employee Stock Purchase Plan (“ESPP”). We recorded expense of $102,899 and $92,180 related to the ESPP during the years ended December 31, 2023 and 2022, respectively.
During the year ended December 31, 2023, we issued an aggregate 46,916 shares of common stock for $224,439 all to employees under our ESPP, as follows:
On May 16, 2023, we issued 22,888 shares for $107,002 for options that vested and were exercised.
On November 15, 2023, we issued 24,028 shares for $117,437 for options that vested and were exercised.
During the year ended December 31, 2022, we issued an aggregate 40,851 shares of common stock for $176,742 all to employees under our ESPP, as follows:
On May 16, 2022, we issued 17,720 shares for $76,666 for options that vested and were exercised.
On November 16, 2022, we issued 23,131 shares for $100,076 for options that vested and were exercised.
Warrants
The following table summarizes the warrants issued and outstanding as of December 31, 2023:
| Warrants Issued and Outstanding as of December 31, 2023 | ||||
|---|---|---|---|---|
| Date of · Exercise · Shares of | ||||
| Description | Issuance | Expiration | Price | Common Stock |
| Exercisable warrants | 10/19/2020 | 3/19/2028 | $1.50 | 500,000 |
| Exercisable warrants | 10/19/2021 | 3/19/2028 | $1.50 | 350,000 |
| Total warrants issued and outstanding | 850,000 | |||
No warrants were issued, exercised or expired during the years ended December 31, 2023 and 2022.
Incentive Compensation Plan
In October 2012, we adopted our 2012 Incentive Compensation Plan, as amended (the “2012 Plan”), as the sole plan for providing equity-based incentive compensation to our employees, non-employee directors, and other service providers. The 2012 Plan allows for the grant of stock options, restricted stock, restricted stock units, stock appreciation rights, performance awards, and other incentive awards to our employees, non-employee directors, and other service providers who are in a position to make a significant contribution to our success and our affiliates. The purpose of the 2012 Plan is to attract and retain individuals, further align employee and stockholder interests, and closely link compensation with our performance. The 2012 Plan is administered by the compensation committee of our board of directors. Our policy is to fulfill any exercise of options from common stock that is authorized and unissued. The maximum number of shares of common stock available for grant under the 2012 Plan is 4,830,437. The number of shares available for award under the 2012 Plan is subject to adjustment for certain corporate changes in accordance with the provisions of the 2012 Plan.
Stock Options
The following table summarizes the stock option activity from January 1, 2022 through December 31, 2023:
| Stock Options | |||
|---|---|---|---|
| Weighted- | |||
| Exercise · Average | |||
| Number | Price Per | Exercise Price | |
| of Shares | Share | Per Share | |
| Outstanding at January 1, 2022 | 3,280,585 | $1.17 — $23.20 | $2.87 |
| Granted | 384,889 | $4.08 — $8.68 | $5.23 |
| Exercised | (414,001) | $1.51 — $6.40 | $1.83 |
| Canceled/Forfeited | (72,085) | $1.51 — $16.80 | $5.76 |
| Outstanding at December 31, 2022 | 3,179,388 | $1.17 — $23.20 | $3.23 |
| Granted | 152,500 | $5.50 | $5.50 |
| Exercised | (418,478) | $1.17 — $4.08 | $2.14 |
| Canceled/Forfeited | (44,397) | $1.51 — $21.20 | $14.42 |
| Outstanding at December 31, 2023 | 2,869,013 | $1.17 — $23.20 | $3.33 |
The weighted-average grant-date fair value of options granted was$3.53 and$3.36 for the years ended December 31, 2023 and 2022, respectively.
For the years ended December 31, 2023 and 2022, the intrinsic value of options outstanding was $11,623,637 and $9,841,358, respectively, and the intrinsic value of options exercisable was $10,877,904 and $8,422,306, respectively.
The following additional information applies to options outstanding at December 31, 2023:
| Range ofExercisePrices | Outstanding atDecember 31, 2023 | Weighted-AverageRemainingContractualLife | Weighted-AverageExercisePrice | Exercisable atDecember 31, 2023 | Weighted-AverageExercisePrice |
|---|---|---|---|---|---|
| $1.17 — $23.20 | 2,869,013 | 5.5 | $3.33 | 2,491,466 | $3.02 |
The following additional information applies to options outstanding at December 31, 2022:
| Range ofExercisePrices | Outstanding atDecember 31, 2022 | Weighted-AverageRemainingContractualLife | Weighted-AverageExercisePrice | Exercisable atDecember 31, 2022 | Weighted-AverageExercisePrice |
|---|---|---|---|---|---|
| $1.17 — $23.20 | 3,179,388 | 6.1 | $3.23 | 2,504,292 | $2.98 |
Stock-Based Compensation
Stock-based compensation expense for stock-based incentive awards was $881,397 and $994,361 for the years ended December 31, 2023 and 2022, respectively. At December 31, 2023, the balance of unearned stock-based compensation to be expensed in future periods related to unvested share-based awards was approximately $1.0 million. The weighted-average period over which the unearned stock-based compensation is expected to be recognized is approximately 2 years.
We account for all stock-based payment awards made to employees and directors, including stock options and employee stock purchases, based on estimated fair values. We estimate the fair value of share-based payment awards on the date of grant using an option-pricing model and the value of the portion of the award is recognized as expense over the requisite service period. We recognize the effects of forfeitures in compensation cost when they occur.
We use the Black-Scholes-Merton option-pricing model as our method of valuation. The fair value is amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. The fair value of share-based payment awards on the date of grant as determined by the Black-Scholes-Merton model is affected by our stock price as well as other assumptions. These assumptions include the expected stock price volatility over the term of the awards, and the actual and projected employee stock option exercise behaviors.
The weighted-average estimated value of employee stock options granted during the years ended December 31, 2023 and 2022 were estimated using the Black-Scholes-Merton option pricing model with the following weighted-average assumptions:
| Years Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Expected volatility | 69% | 71% |
| Risk-free interest rate | 3.58% | 2.79% |
| Expected dividends | 0.00% | 0.00% |
| Expected term in years | 6.0 | 5.9 |
Deferred Stock Units
During the year ended December 31, 2023, we granted 6,131 DSUs and recorded director compensation expense of $40,732 related to the grants. In addition, during the year ended December 31, 2023, we granted 14,089 DSUs to executive employees and recorded compensation expense of $118,162. During the year ended December 31, 2022, we granted 6,719 DSUs and recorded director compensation expense of $39,142 related to the grants. In addition, during the year ended December 31, 2022, we granted 35,201 DSUs to executive employees and recorded compensation expense of $157,885. We had 231,635 and 211,415 DSUs outstanding at December 31, 2023 and 2022, respectively.
Restricted Stock Units
During the year ended December 31, 2023, we granted restricted stock units (“RSUs”) to nonemployee directors as part of their annual board compensation. The RSUs are recognized at their fair value on the date of grant. Each RSU represents the right to receiveone share of our common stock once fully vested. During the year ended December 31, 2023, we granted 61,056 RSUs and recorded director compensation expense of $169,203 related to the grants. We had 61,056 and 0 RSUs outstanding at December 31, 2023 and 2022, respectively. These RSUs werenot vested at December 31, 2023.
- Net Loss per Share
We compute basic net loss per share using the weighted average number of shares of common stock outstanding plus the number of common stock equivalents for DSUs during the period. We compute diluted net income (loss) per share using the weighted average number of shares of common stock outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods where losses are reported, the weighted average number of shares of common stock outstanding excludes common stock equivalents because their inclusion would be anti-dilutive. Dilutive potential common shares consist of the incremental common shares issuable upon the exercise of outstanding stock options and warrants. Dilutive potential securities are excluded from the computation of earnings per share if their effect is antidilutive. The dilutive effect of outstanding stock options and warrants is reflected in diluted earnings per share by application of the treasury stock method.
The computation of basic and diluted net loss per share attributable to common stockholders is as follows:
| Years Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Numerator: | ||
| Net loss | $(7,291,285) | $(6,047,986) |
| Denominator: | ||
| Weighted average common shares outstanding, basic | 20,123,221 | 19,473,786 |
| Effect of dilutive securities | — | — |
| Weighted average common shares outstanding, diluted | 20,123,221 | 19,473,786 |
| Net loss per share | ||
| Basic | $(0.36) | $(0.31) |
| Diluted | $(0.36) | $(0.31) |
| Anti-dilutive securities excluded from diluted net loss per share | ||
| Stock options | 62,968 | 244,907 |
| Total anti-dilutive securities excluded from diluted net loss per share | 62,968 | 244,907 |
- Supplemental Cash Flow Information
The following is provided as supplemental information to the consolidated statements of cash flows:
| Years Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Supplemental cash flow information: | ||
| Cash paid for interest | $8,568,312 | $5,720,406 |
| Cash paid for income taxes | $366,361 | $330,866 |
| Supplemental non-cash activities: | ||
| Seller consideration settled in shares of common stock | $— | $1,342,125 |
- Related Party Transactions
See Note 7 for further information regarding a promissory note issued to the seller of Green Remedies in connection with the Green Remedies acquisition.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.